ANROVSHAE• 12 Months (Normalized)
ANRO vs HAE (Alto Neuroscience Inc. vs Haemonetics Corporation)
Showing Closing Date Range from Oct 7, 2025 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $23.69
+298.82%
Alto Neuroscience Inc.
Normalized Baseline0.00%
HAE Performance $103.52
+110.15%
Haemonetics Corporation
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+188.67 pts
ANRO outperforming by 188.67 percentage points
ANROHAE
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO HAE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | ANRO Price | ANRO Gain (%) | HAE Price | HAE Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $23.69 | +298.82% | $103.52 | +110.15% | +188.67% |
| Oct 05, 2026 | $24.01 | +304.21% | $104.68 | +112.51% | +191.70% |
| Oct 02, 2026 | $24.80 | +317.51% | $104.68 | +112.51% | +205.00% |
| Oct 01, 2026 | $- | $104.37 | +111.88% | - | |
| Sep 30, 2026 | $25.88 | +335.69% | $105.30 | +113.76% | +221.93% |
| Sep 29, 2026 | $26.58 | +347.47% | $105.80 | +114.78% | +232.69% |
| Sep 28, 2026 | $26.66 | +348.82% | $105.79 | +114.76% | +234.06% |
| Sep 25, 2026 | $26.49 | +345.96% | $105.30 | +113.76% | +232.20% |
| Sep 24, 2026 | $27.18 | +357.58% | $- | - | |
| Sep 23, 2026 | $27.50 | +362.96% | $106.82 | +116.85% | +246.11% |
| Sep 22, 2026 | $30.78 | +418.18% | $108.52 | +120.30% | +297.88% |
| Sep 21, 2026 | $30.63 | +415.66% | $108.73 | +120.73% | +294.93% |
| Sep 18, 2026 | $30.27 | +409.60% | $108.40 | +120.06% | +289.54% |
| Sep 17, 2026 | $30.98 | +421.55% | $107.60 | +118.43% | +303.12% |
| Sep 16, 2026 | $30.00 | +405.05% | $106.24 | +115.67% | +289.38% |
Page 1 of 17